Barclays’s Aoxing Pharmaceutical Company Inc. AXN Stock Holding History

Barclays’s Portfolio AXN Stock Details AXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25,000	Closed	-$4K	–	7342
2017 Q3	$4K	Hold	25,000	–	–	﹤0.01%	6555
2017 Q2	$8K	Hold	25,000	–	–	﹤0.01%	6136
2017 Q1	$10K	Hold	25,000	–	–	﹤0.01%	6095
2016 Q4	$8K	Hold	25,000	–	–	﹤0.01%	6005
2016 Q3	$14K	Hold	25,000	–	–	﹤0.01%	5658
2016 Q2	$16K	Buy	+25,000	New	+$16.9K	﹤0.01%	5383

Barclays's AXN Position: Q4 2017 in Review

Barclays sold out of Aoxing Pharmaceutical Company Inc. (AXN) in Q4 2017, closing a stake of 25,000 shares — an estimated $4K sold.

Barclays first reported a position in AXN in Q2 2016 and held it in 6 quarters. The position peaked at $16K in Q2 2016. 0 funds tracked by Wall St. Rank hold AXN as of Q4 2017.

Barclays reported no remaining Aoxing Pharmaceutical Company Inc. position as of Q4 2017 after selling out during the quarter.
Barclays sold 25,000 Aoxing Pharmaceutical Company Inc. shares in Q4 2017, an estimated $4K.
Barclays first reported a position in Aoxing Pharmaceutical Company Inc. in Q2 2016 and held it in 6 quarters.
Barclays's Aoxing Pharmaceutical Company Inc. position peaked at $16K in Q2 2016.
0 funds tracked by Wall St. Rank held Aoxing Pharmaceutical Company Inc. as of Q4 2017.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.